Tumor lysis syndrome in a multiple myeloma treated with thalidomide

Ann Oncol. 2004 Mar;15(3):537. doi: 10.1093/annonc/mdh116.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Thalidomide / adverse effects*
  • Tumor Lysis Syndrome / etiology*

Substances

  • Antineoplastic Agents
  • Thalidomide